These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Perioperative complications after hepatectomy with or without intra-arterial chemotherapy for bilobar colorectal cancer liver metastases. Tanaka K; Shimada H; Ueda M; Matsuo K; Endo I; Sekido H; Togo S Surgery; 2006 May; 139(5):599-607. PubMed ID: 16701091 [TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary (Br J Surg 2006; 93; 872-878). Verhoef C; Nuytens JJ; Planting AS; de Wilt JH Br J Surg; 2007 Feb; 94(2):250. PubMed ID: 17256815 [No Abstract] [Full Text] [Related]
25. A critical appraisal of the role of neoadjuvant chemotherapy for colorectal liver metastases: a case-controlled study. Malik HZ; Farid S; Al-Mukthar A; Anthoney A; Toogood GJ; Lodge JP; Prasad KR Ann Surg Oncol; 2007 Dec; 14(12):3519-26. PubMed ID: 17912590 [TBL] [Abstract][Full Text] [Related]
26. Response to chemotherapy predicts survival following resection of hepatic colo-rectal metastases in patients treated with neoadjuvant therapy. Small RM; Lubezky N; Shmueli E; Figer A; Aderka D; Nakache R; Klausner JM; Ben-Haim M J Surg Oncol; 2009 Feb; 99(2):93-8. PubMed ID: 19065637 [TBL] [Abstract][Full Text] [Related]
27. [Neoadjuvant chemotherapy as a treatment strategy for multiple bilobar liver metastases from colorectal carcinoma]. Suzuki S; Sakaguchi T; Nakamura T; Nakamura S; Konno H Nihon Geka Gakkai Zasshi; 2006 May; 107(3):128-32. PubMed ID: 16734269 [TBL] [Abstract][Full Text] [Related]
28. [Liver resection after downstaging with neoadjuvant chemotherapy for "unresectable" colorectal metastases]. Frena A; Martin F; La Guardia G; Vezzali N; Bonatti G; Stocker J; Graiff C Chir Ital; 2004; 56(3):351-7. PubMed ID: 15287631 [TBL] [Abstract][Full Text] [Related]
29. [Colorectal cancer liver metastases -- neoadjuvant concepts for preoperative down-sizing]. Golling M; Gog C; Woeste G; Zapletal C; Wullstein C; Bechstein WO Zentralbl Chir; 2006 Apr; 131(2):140-7. PubMed ID: 16612781 [TBL] [Abstract][Full Text] [Related]
30. Infectious complications in combined colon resection and ablation of colorectal liver metastases. Doughtie CA; Edwards JD; Philips P; Agle SC; Scoggins CR; McMasters KM; Martin RC Am J Surg; 2015 Dec; 210(6):1185-90; discussion 1190-1. PubMed ID: 26482514 [TBL] [Abstract][Full Text] [Related]
31. Targeted molecular therapies (cetuximab and bevacizumab) do not induce additional hepatotoxicity: preliminary results of a case-control study. Pessaux P; Panaro F; Casnedi S; Zeca I; Marzano E; Bachellier P; Jaeck D; Chenard MP Eur J Surg Oncol; 2010 Jun; 36(6):575-82. PubMed ID: 20452168 [TBL] [Abstract][Full Text] [Related]
32. [Choice of surgical strategy for colorectal liver metastases depending on clinical and pathological response to neoadjuvant chemo- and targeted therapy]. Jakab F Orv Hetil; 2010 Nov; 151(47):1956-60. PubMed ID: 21071308 [TBL] [Abstract][Full Text] [Related]
33. [Timing of resection in patients with colorectal carcinoma and synchronous liver metastases]. Hopt UT; Drognitz O; Neeff H Zentralbl Chir; 2009 Sep; 134(5):425-9. PubMed ID: 19757342 [TBL] [Abstract][Full Text] [Related]
34. Colorectal cancer metastases: surgical indications and multimodal approach. Ciferri E; Bondanza GS; Municinò O; Castagnola M; Gazzaniga GM Hepatogastroenterology; 2003; 50(54):1836-46. PubMed ID: 14696416 [TBL] [Abstract][Full Text] [Related]
35. Volumetric analysis of remnant liver regeneration after major hepatectomy in bevacizumab-treated patients: a case-matched study in 82 patients. Millet G; Truant S; Leteurtre E; Hebbar M; Zerbib P; Huet G; Boleslawski E; Pruvot FR Ann Surg; 2012 Nov; 256(5):755-61; discussion 761-2. PubMed ID: 23095619 [TBL] [Abstract][Full Text] [Related]
36. Comparison of oncological outcomes between neoadjuvant and adjuvant chemotherapy combined with surgery for resectable synchronous colorectal liver metastases. Oh SY; Kim DY; Kim YB; Suh KW J Surg Res; 2013 Jun; 182(2):257-63. PubMed ID: 23253254 [TBL] [Abstract][Full Text] [Related]
37. The extent of resection influences outcome following hepatectomy for colorectal liver metastases. Stewart GD; O'Súilleabháin CB; Madhavan KK; Wigmore SJ; Parks RW; Garden OJ Eur J Surg Oncol; 2004 May; 30(4):370-6. PubMed ID: 15063889 [TBL] [Abstract][Full Text] [Related]
39. Effect of bevacizumab added preoperatively to oxaliplatin on liver injury and complications after resection of colorectal liver metastases. van der Pool AE; Marsman HA; Verheij J; Ten Kate FJ; Eggermont AM; Ijzermans JN; Verhoef C J Surg Oncol; 2012 Dec; 106(7):892-7. PubMed ID: 22552819 [TBL] [Abstract][Full Text] [Related]
40. [Hepatic resection after neoadjuvant therapy for initially unresectable colorectal liver metastases]. Kaibori M; Iwamoto S; Ishizaki M; Matsui K; Saito T; Yoshioka K; Kwon AH Gan To Kagaku Ryoho; 2009 Dec; 36(13):2579-82. PubMed ID: 20009458 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]